Geode Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.4M Sell
2,252,420
-42,611
-2% -$215K ﹤0.01% 2276
2025
Q1
$14.9M Buy
2,295,031
+98,430
+4% +$638K ﹤0.01% 2062
2024
Q4
$16.1M Buy
2,196,601
+7,827
+0.4% +$57.5K ﹤0.01% 2073
2024
Q3
$16.4M Buy
2,188,774
+5,146
+0.2% +$38.5K ﹤0.01% 2088
2024
Q2
$19.4M Buy
2,183,628
+234,439
+12% +$2.09M ﹤0.01% 1939
2024
Q1
$19.7M Buy
1,949,189
+62,793
+3% +$636K ﹤0.01% 1937
2023
Q4
$19M Buy
1,886,396
+92,532
+5% +$931K ﹤0.01% 1954
2023
Q3
$16.8M Buy
1,793,864
+103,087
+6% +$966K ﹤0.01% 1939
2023
Q2
$41.5M Buy
1,690,777
+165,359
+11% +$4.06M ﹤0.01% 1379
2023
Q1
$35.5M Buy
1,525,418
+59,140
+4% +$1.38M ﹤0.01% 1426
2022
Q4
$37.1M Buy
1,466,278
+50,049
+4% +$1.27M 0.01% 1357
2022
Q3
$27.3M Buy
1,416,229
+37,360
+3% +$720K ﹤0.01% 1520
2022
Q2
$35.1M Buy
1,378,869
+133,478
+11% +$3.4M 0.01% 1360
2022
Q1
$32M Buy
1,245,391
+13,571
+1% +$349K ﹤0.01% 1568
2021
Q4
$51.6M Buy
1,231,820
+36,062
+3% +$1.51M 0.01% 1286
2021
Q3
$52M Buy
1,195,758
+28,418
+2% +$1.24M 0.01% 1240
2021
Q2
$55.2M Buy
1,167,340
+89,918
+8% +$4.25M 0.01% 1216
2021
Q1
$55.2M Buy
1,077,422
+111,047
+11% +$5.69M 0.01% 1147
2020
Q4
$25.9M Buy
966,375
+52,065
+6% +$1.39M ﹤0.01% 1552
2020
Q3
$31.4M Buy
914,310
+524,887
+135% +$18M 0.01% 1192
2020
Q2
$16M Buy
389,423
+273,143
+235% +$11.2M ﹤0.01% 1653
2020
Q1
$3.98M Buy
116,280
+81,001
+230% +$2.78M ﹤0.01% 2271
2019
Q4
$443K Buy
+35,279
New +$443K ﹤0.01% 3541